A multicenter phase II randomized study of docetaxel (D)/gemcitabine (G) weekly followed by erlotinib (E) after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non-small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA): Groupe Français de Pneumocancerologie (GFPC)*0504.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 7536-7536
Author(s):  
H. Le Caer ◽  
F. Barlesi ◽  
R. Corre ◽  
H. Jullian ◽  
S. Bota ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Geriatric Assessment ◽  
Phase Ii ◽  
Comprehensive Geriatric Assessment ◽  
Randomized Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicenter Phase

scholarly journals Weekly Paclitaxel Combined with Monthly Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

2006 ◽  
Vol 1 (4) ◽  
pp. 328-334 ◽  
Author(s):  
Jean-Louis Pujol ◽  
Bernard Milleron ◽  
Olivier Molinier ◽  
Elisabeth Quoix ◽  
Alain Depierre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Weekly Paclitaxel ◽  
Small Cell Lung ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document